A Flawed Study Shows How Little We Understand Crispr's Effects

A Flawed Study Shows How Little We Understand Crispr's Effects

  • Af
  • Episode
      492
  • Published
      4. apr. 2018
  • Forlag
0 Anmeldelser
0
Episode
492 of 2361
Længde
5M
Sprog
Engelsk
Format
Kategori
Fakta

Biotech has been betting big on Crispr, the gene-editing technique that promises to snip away some of humanity’s worst diseases. But last May, a small case study suggested the much-hyped technology might actually be quite dangerous—and pop went the Crispr bubble, briefly tanking shares of Crispr companies like Editas Medicine, Intellia Therapeutics, and Crispr Therapeutics.

Learn about your ad choices: dovetail.prx.org/ad-choices


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for A Flawed Study Shows How Little We Understand Crispr's Effects

Other podcasts you might like ...